Caladrius BioSciences   (NASDAQ:CLBS)

Caladrius is pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease.Our business includes the development of novel proprietary cell therapy products, as well as a revenue-generating contract development and manufacturing service business that we leverage for the development of our therapeutics while providing service to other companies in the cell therapy industry.

© 2019 by Dynamic Market Concepts

  • Facebook - Black Circle
  • Twitter - Black Circle
  • Google+ - Black Circle